• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

催眠药与事故及伤害之间的关联:一项基于日本药品不良事件报告数据库的研究。

Association Between Hypnotics, Accidents, and Injuries: A Study Based on the Adverse Drug Event Reporting Database in Japan.

作者信息

Sogawa Rintaro, Hatano Masakazu, Nishimura Fumi, Nishi Junya, Matsuoka Ayaka, Shinada Kota, Yamada Haruna, Tateishi Hiroshi, Mizoguchi Yoshito, Monji Akira, Shimanoe Chisato

机构信息

Department of Pharmacy, Saga University Hospital, Nabeshima, Japan;

Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, Toyoake, Japan.

出版信息

In Vivo. 2025 Jan-Feb;39(1):433-439. doi: 10.21873/invivo.13846.

DOI:10.21873/invivo.13846
PMID:39740920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11705136/
Abstract

BACKGROUND/AIM: The use of hypnotic drugs can lead to accidents and injuries. However, few reports have shown their association with these events after adjusting for many concomitant medications. This study aimed to determine whether the use of hypnotic drugs was associated with accidents and injuries.

PATIENTS AND METHODS

Using the Japanese Adverse Event Reporting Database, 772,387 reports published between September 2023 and April 2004 were analyzed. Reporting odds ratios (RORs) and 95% confidence intervals (CIs) for accidents and injuries associated with each hypnotic drug were calculated after adjusting for potential confounders.

RESULTS

Of the total, 12,484 reports indicated association of hypnotic drugs with accidents and injuries. The use of each hypnotic drug was associated with accidents, injuries, and other adverse events. However, a multivariate analysis adjusted for age, sex, reporting year, and concomitant medications showed a considerable decrease in ROR for melatonin receptor agonists (adjusted ROR=1.26; 95%CI=1.03-1.55) and dual orexin receptor antagonists (DORAs) (adjusted ROR=1.04; 95%CI=0.86-1.25). Particularly in DORAs, a loss of signal for accidents and injuries was observed.

CONCLUSION

The risk of accidents and injuries may vary with hypnotic drug use; however, DORAs may be less frequently associated with these events. The results of this study provide useful information for the selection of hypnotic drugs.

摘要

背景/目的:使用催眠药物可能导致事故和伤害。然而,在对多种合并用药进行调整后,很少有报告显示它们与这些事件之间的关联。本研究旨在确定使用催眠药物是否与事故和伤害有关。

患者和方法

使用日本不良事件报告数据库,分析了2003年9月至2004年4月期间发表的772387份报告。在对潜在混杂因素进行调整后,计算了每种催眠药物相关的事故和伤害的报告比值比(ROR)和95%置信区间(CI)。

结果

总共12484份报告表明催眠药物与事故和伤害有关。每种催眠药物的使用都与事故、伤害和其他不良事件有关。然而,在对年龄、性别、报告年份和合并用药进行多变量分析后,褪黑素受体激动剂(调整后的ROR = 1.26;95%CI = 1.03 - 1.55)和双食欲素受体拮抗剂(DORAs)(调整后的ROR = 1.04;95%CI = 0.86 - 1.25)的ROR显著降低。特别是在DORAs中,观察到事故和伤害的信号消失。

结论

事故和伤害的风险可能因催眠药物的使用而异;然而,DORAs与这些事件的关联可能较少。本研究结果为催眠药物的选择提供了有用信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4a/11705136/128e95199cb5/in_vivo-39-434-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4a/11705136/128e95199cb5/in_vivo-39-434-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4a/11705136/128e95199cb5/in_vivo-39-434-g0001.jpg

相似文献

1
Association Between Hypnotics, Accidents, and Injuries: A Study Based on the Adverse Drug Event Reporting Database in Japan.催眠药与事故及伤害之间的关联:一项基于日本药品不良事件报告数据库的研究。
In Vivo. 2025 Jan-Feb;39(1):433-439. doi: 10.21873/invivo.13846.
2
[Assessment of the Relationship between Hypnotics and Delirium Using the Japanese Adverse Drug Event Report (JADER) Database].[使用日本药品不良反应事件报告(JADER)数据库评估催眠药与谵妄之间的关系]
Yakugaku Zasshi. 2018;138(7):985-990. doi: 10.1248/yakushi.17-00221.
3
Hypnotics and infections: disproportionality analysis of the U.S. Food & Drug Administration adverse event reporting system database.催眠药物和感染:美国食品和药物管理局不良事件报告系统数据库的比例失调分析。
J Clin Sleep Med. 2022 Sep 1;18(9):2229-2235. doi: 10.5664/jcsm.10094.
4
Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.药物相关性急性肾损伤在美国食品和药物管理局不良事件报告系统数据库中的识别。
Pharmacotherapy. 2018 Aug;38(8):785-793. doi: 10.1002/phar.2152. Epub 2018 Jul 13.
5
Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.最常导致急性肾损伤的药物监测:一种药物警戒方法。
J Clin Pharm Ther. 2019 Feb;44(1):49-53. doi: 10.1111/jcpt.12748. Epub 2018 Jul 16.
6
Analysis of Drug-Related Tinnitus Based on the FDA Adverse Event Reporting System Database.基于美国食品药品监督管理局不良事件报告系统数据库的药物相关性耳鸣分析
Br J Hosp Med (Lond). 2024 Dec 30;85(12):1-12. doi: 10.12968/hmed.2024.0380. Epub 2024 Jul 16.
7
Association Between Antidiabetic Drugs and Delirium: A Study Based on the Adverse Drug Event Reporting Database in Japan.抗糖尿病药物与谵妄的相关性:基于日本药物不良反应报告数据库的研究。
Clin Drug Investig. 2024 Feb;44(2):115-120. doi: 10.1007/s40261-023-01337-9. Epub 2023 Dec 23.
8
Disproportionality Analysis of Hepatotoxic and Gastrointestinal Adverse Events Associated With Nintedanib Using the Japanese Adverse Drug Event Report (JADER) Database.使用日本药品不良事件报告(JADER)数据库对与尼达尼布相关的肝毒性和胃肠道不良事件进行不成比例分析。
In Vivo. 2025 Jan-Feb;39(1):396-403. doi: 10.21873/invivo.13841.
9
Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database.使用两个大型数据库分析抗胆碱能不良反应:美国食品和药物管理局不良事件报告系统数据库和日本药物不良反应报告数据库。
PLoS One. 2021 Dec 2;16(12):e0260980. doi: 10.1371/journal.pone.0260980. eCollection 2021.
10
An exploratory study evaluating the 20 medications most commonly associated with suicidal ideation and self-injurious behavior in the FAERS database.一项探索性研究,评估FAERS数据库中与自杀意念和自伤行为最常相关的20种药物。
BMC Pharmacol Toxicol. 2025 Jan 30;26(1):24. doi: 10.1186/s40360-025-00858-7.

本文引用的文献

1
Association of Antiviral Drugs for the Treatment of COVID-19 With Acute Renal Failure.抗病毒药物治疗 COVID-19 与急性肾衰竭的关联。
In Vivo. 2024 Jul-Aug;38(4):1841-1846. doi: 10.21873/invivo.13637.
2
The Administration of Lemborexant at Admission is Not Associated with Inpatient Falls: A Multicenter Retrospective Observational Study.入院时使用伦博瑞生与住院患者跌倒无关:一项多中心回顾性观察研究。
Int J Gen Med. 2024 Mar 25;17:1139-1144. doi: 10.2147/IJGM.S452278. eCollection 2024.
3
Association Between Antidiabetic Drugs and Delirium: A Study Based on the Adverse Drug Event Reporting Database in Japan.
抗糖尿病药物与谵妄的相关性:基于日本药物不良反应报告数据库的研究。
Clin Drug Investig. 2024 Feb;44(2):115-120. doi: 10.1007/s40261-023-01337-9. Epub 2023 Dec 23.
4
Proton Pump Inhibitors Ameliorate Oxaliplatin-induced Peripheral Neuropathy: Retrospective Analysis of Two Real-world Clinical Databases.质子泵抑制剂改善奥沙利铂诱导的周围神经病:两项真实世界临床数据库的回顾性分析。
Anticancer Res. 2023 Dec;43(12):5613-5620. doi: 10.21873/anticanres.16764.
5
Analysis of clozapine-induced seizures using the Japanese Adverse Drug Event Report database.利用日本不良药物事件报告数据库分析氯氮平引起的癫痫发作。
PLoS One. 2023 Jun 12;18(6):e0287122. doi: 10.1371/journal.pone.0287122. eCollection 2023.
6
Association between nocturnal falls and hypnotic drug use in older patients at acute care hospitals.急性护理医院老年患者夜间跌倒与催眠药物使用的关联。
Eur J Clin Pharmacol. 2023 Jun;79(6):753-758. doi: 10.1007/s00228-023-03485-5. Epub 2023 Apr 3.
7
A pharmacovigilance approach for assessing the occurrence of suicide-related events induced by antiepileptic drugs using the Japanese adverse drug event report database.利用日本药品不良事件报告数据库,采用药物警戒方法评估抗癫痫药物诱发的自杀相关事件的发生情况。
Front Psychiatry. 2023 Jan 9;13:1091386. doi: 10.3389/fpsyt.2022.1091386. eCollection 2022.
8
Therapeutic dilemmas with benzodiazepines and Z-drugs: insomnia and anxiety disorders versus increased fall risk: a clinical review.苯二氮䓬类药物和 Z 类药物的治疗困境:失眠和焦虑症与跌倒风险增加:临床综述。
Eur Geriatr Med. 2023 Aug;14(4):697-708. doi: 10.1007/s41999-022-00731-4. Epub 2022 Dec 28.
9
Association of orexin receptor antagonists with falls during hospitalization.食欲素受体拮抗剂与住院期间跌倒的关联。
J Clin Pharm Ther. 2022 Jun;47(6):809-813. doi: 10.1111/jcpt.13619. Epub 2022 Mar 1.
10
Pharmacological Management of Insomnia.失眠的药物治疗。
Neurotherapeutics. 2021 Jan;18(1):44-52. doi: 10.1007/s13311-021-01010-z. Epub 2021 Feb 1.